New Conception of Relining in the Endovascular Aneurysm Sealing Era: A Monocentric Case Series Study

Saitta, Giuseppe; Gennai, Stefano; Munari, Elisa; Borsari, Giulia; Lauricella, Antonio; Migliari, Mattia; Silingardi, Roberto

doi:10.1016/j.avsg.2018.07.074

Cited by 5 publications

(7 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The endobag conformation prevents the gutter formation by gaining a relining of all primary endograft segments. 18 Bilirubin levels may be elevated due to hematological disorders, impaired liver function and cholestasis. Bilirubin is a fundamental metabolic ultimate product of heme degradation and its increase can be caused by hemolysis.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

An unusual complication after endovascular aneurysm repair for giant abdominal aortic aneurysm with aortocaval fistula: High bilirubin levels

Marchetti

Oddi

Diotallevi

et al. 2020

SAGE Open Medical Case Reports

View full text Add to dashboard Cite

Abdominal aortic aneurysm has among its rare complications the aortocaval fistula. It is observed in less than 1% of all abdominal aortic aneurysms and represents 3%–7% of clinical presentation in case of rupture. A male patient was presented to the emergency department with pulsating mass with continuous vascular systo-diastolic bruit, located in the lower part of abdomen with the back pain radiating anteriorly in lower abdomen. After diagnosis of abdominal aortic aneurysm with aortocaval fistula, a trimodular Endurant endograft was placed. Migration of the endoprosthesis was treated with Endoanchor and endovascular aneurysm sealing device. In the postoperative course, the patient had jaundice due to high bilirubin levels, cholestasis and increased hepatocyte cytolysis: aspartate aminotransferase and alanine aminotransferase. The treatment with appropriate continuous filtration rapidly reduced bilirubin values and the patient gradually improved.

show abstract

Section: Discussionmentioning

confidence: 99%

“…experience. 17 , 18 For this reason, no negligible risk of dislodgment with the use of coils was assumed.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

An unusual complication after endovascular aneurysm repair for giant abdominal aortic aneurysm with aortocaval fistula: High bilirubin levels

Marchetti

Oddi

Diotallevi

et al. 2020

SAGE Open Medical Case Reports

View full text Add to dashboard Cite

show abstract

“…EVAS has already been successfully applied in type Ia endoleaks after prior EVAR or EVAS on short-term follow-up. [9][10][11][12][13] So far only a few cases [14][15][16][17][18] have been described to present the outcome of EVAS for type III endoleaks, showing technical feasibility. The objective of this study was to analyze clinical outcomes of EVAS for type III endoleaks after EVAR on a larger scale.…”

Section: Introductionmentioning

confidence: 99%

“…So far only a few cases 14 - 18 have been described to present the outcome of EVAS for type III endoleaks, showing technical feasibility. The objective of this study was to analyze clinical outcomes of EVAS for type III endoleaks after EVAR on a larger scale.…”

Section: Introductionmentioning

confidence: 99%

An International, Multicenter Retrospective Observational Study to Assess Technical Success and Clinical Outcomes of Patients Treated with an Endovascular Aneurysm Sealing Device for Type III Endoleak

et al. 2021

Self Cite

View full text Add to dashboard Cite

Introduction: Type III endoleaks post-endovascular aortic aneurysm repair (EVAR) warrant treatment because they increase pressure within the aneurysm sac leading to increased rupture risk. The treatment may be difficult with regular endovascular devices. Endovascular aneurysm sealing (EVAS) might provide a treatment option for type III endoleaks, especially if located near the flow divider. This study aims to analyze clinical outcomes of EVAS for type III endoleaks after EVAR. Methods: This is an international, retrospective, observational cohort study including data from 8 European institutions. Results: A total of 20 patients were identified of which 80% had a type IIIb endoleak and the remainder (20%) a type IIIa endoleak. The median time between EVAR and EVAS was 49.5 months (28.5–89). Mean AAA diameter prior to EVAS revision was 76.6±19.9 mm. Technical success was achieved in 95%, 1 patient had technical failure due to a postoperative myocardial infarction resulting in death. Mean follow-up was 22.8±15.2 months. During follow-up 1 patient had a type Ia endoleak, and 1 patient had a new type IIIa endoleak at an untreated location. There were 5 patients with aneurysm growth. Five patients underwent AAA-related reinterventions indications being: growth with type II endoleak (n=3), type Ia endoleak (n=1), and iliac aneurysm (n=1). At 1-year follow-up, the freedom from clinical failure was 77.5%, freedom from all-cause mortality 94.7%, freedom from aneurysm-related mortality 95%, and freedom from aneurysm-related reinterventions 93.8%. Conclusion: The EVAS relining can be safely performed to treat type III endoleaks with an acceptable technical success rate, a low 30-day mortality rate and no secondary ruptures at short-term follow-up. The relatively low clinical success rates, related to reinterventions and AAA enlargement, highlight the need for prolonged follow-up.

show abstract

Endoleak Types IV and V

Duvnjak

2020

Endovascular Abdominal Aortic Repair- Endoleak Treatment

View full text Add to dashboard Cite

New Conception of Relining in the Endovascular Aneurysm Sealing Era: A Monocentric Case Series Study

Cited by 5 publications

References 13 publications

An unusual complication after endovascular aneurysm repair for giant abdominal aortic aneurysm with aortocaval fistula: High bilirubin levels

An unusual complication after endovascular aneurysm repair for giant abdominal aortic aneurysm with aortocaval fistula: High bilirubin levels

An International, Multicenter Retrospective Observational Study to Assess Technical Success and Clinical Outcomes of Patients Treated with an Endovascular Aneurysm Sealing Device for Type III Endoleak

Endoleak Types IV and V

Contact Info

Product

Resources

About